Hypnotics and skin cancer: hint at drug carcinogenesis, coincidence, or benefit of more sleep?
Gary D
GD
Friedman
D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use; D000818:Animals; D053961:Azabicyclo Compounds / Q000009:adverse effects* / Q000627:therapeutic use; D002280:Basal Cell Carcinoma / Q000139:chemically induced*; D000069582:Eszopiclone; D006801:Humans; D007192:Indenes / Q000009:adverse effects* / Q000627:therapeutic use; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012878:Skin Neoplasms / Q000139:chemically induced*; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000081:Acetamides; D053961:Azabicyclo Compounds; D007192:Indenes; D010879:Piperazines; D011743:Pyrimidines; C495910:ramelteon; C085665:zaleplon; D000069582:Eszopiclone